Chemical Structure (Vytorin 01)
Vytorin Tablet
Product Images NDC 78206-177
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vytorin (NDC 78206-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Vytorin 02)
Figure 1 (Vytorin 03)
The text shows a graph comparing the occurrence of major vascular events between two groups of patients: Placebo (Pbo) and VYTORIN (VYT). The graph shows that there were significantly fewer major vascular events in patients taking VYTORIN than those taking Placebo. The difference in occurrence is significant with a P-value of 0.001. Follow-up was done for up to 5 years. At the beginning of the study, there were 4191 patients in the Placebo group and 4193 patients in the VYTORIN group. The number of patients decreased over time due to patients leaving the study or experiencing major vascular events.*
Principal Display Panel (10 mg /10 mg Tablet Bottle Label)
This is a description of a medication called Vytorin. The medication comes in tablet form and each tablet contains 10 mg ezetimibe and 10 mg simvastatin. The medication is manufactured by Organon and has an NDC code of 78206-174-01. There is also a reserved area for 2D serialization barcode, serial number, expiry, and lot on the packaging.*
Principal Display Panel (10 mg /20 mg Tablet Bottle Label)
This is a description of a prescription medication called "VTS Organon". The medication comes in tablet form and contains 10mg of ezetimibe and 20mg of simvastatin. The medication is available only through a prescription, and details about serialization, including barcode and lot number, are reserved in a specific area on the packaging.*
Principal Display Panel (10 mg /40 mg Tablet Bottle Label)
This is a description of the Organon medication containing ezetimibe and simvastatin tablets. Each tablet consists of 10 mg of ezetimibe and 40 mg of simvastatin which is used to reduce cholesterol in the body. The encoding area is kept reserved for the 2D serialization barcode, serial number, expiry, and lot. The medication is only allowed if prescribed by medical personnel as per the usual dosage mentioned in the package insert. The container should be kept at a temperature between 20-25°C (68-77°F). The package contains 30 tablets.*
Principal Display Panel (10 mg /80 mg Tablet Bottle Label)
This text is describing a medication called Vytorin, which comes in tablet form and contains two active ingredients, 10mg of ezetimibe and 80mg of simvastatin. The medication should be stored in a tightly closed container at a temperature between 20-25°C. The dosage of the medication should follow the package insert. The text mentions an organization named Organon & Co. that is a subsidiary of the larger umbrella company called Schering-Plough. The packaging of the medication also has a reserved space for 2D Serialization Barcode, Serial Number, Expiry, and Lot.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
